716 / 1138
•
Medically inoperable patients with biopsy proven, PET staged
T1-2N0M0 NSCLC, ≤ 5 cm centrally located tumors
•
100 evaluable patients from 43 centers (2009-2013)
•
Of the 12 excluded patients, 8 did not meet eligibility criteria.
•
Median age 72 years (range 52- 89), 45% squamous cell
carcinoma,
65% had T1 tumors
.
•
Median follow up was 26.6 months.
Bezjak A, WCLC Denver (Oral 19.03, 8
th
September 2015)